Literature DB >> 17681992

Patients with diabetic nephropathy on renal replacement therapy in England and Wales.

D Nitsch1, R Burden, R Steenkamp, D Ansell, C Byrne, F Caskey, P Roderick, T Feest.   

Abstract

BACKGROUND: The incidence of patients with diabetic nephropathy (DN) who start renal replacement therapy (RRT) is increasing. AIM: To describe the characteristics and survival of patients with DN starting RRT in the UK.
DESIGN: Retrospective cohort study.
METHODS: We analysed data for incident patients on RRT in centres participating in the Renal Association UK Renal Registry (UKRR), 1997 -2004, comparing DN vs. non-DN patients with regard to survival, social deprivation, ethnicity, gender, and age, using Cox regression models.
RESULTS: DN was the most common renal disease (19%) in the 20 532 patients starting RRT. The majority of patients with DN (77%) were Caucasian. Within the Caucasian population, DN patients were more likely to be from a socially deprived area (p < 0.0001). About 20% were referred <3 months before starting RRT. The difference in crude survival was greatest in younger patients (5-year survival was 56% (DN) vs. 85% (non-DN) in patients aged 18-54 years, and 17% (DN) vs. 28% (non-DN) in patients aged >or=65 years). Despite adjusting for gender, age, treatment modality, social deprivation, referral and co-morbidities, the long-term prognosis for DN patients aged 18-54 years was worse (adjusted hazard ratio 2.13, 95%CI 1.23-3.67) than for older age groups. DISCUSSION: Patients with DN starting RRT are more likely to come from socially deprived areas. Relative risk of death is greatest in working-age DN patients and is not fully explained by recorded co-morbidity. This emphasizes the need for focused diabetes care in poorer areas, and assessment of quality of care of diabetic patients on RRT.

Entities:  

Mesh:

Year:  2007        PMID: 17681992     DOI: 10.1093/qjmed/hcm062

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  5 in total

1.  Predicting diabetic nephropathy by serum proteomic profiling in patients with type 2 diabetes.

Authors:  Yehong Yang; Shuo Zhang; Bin Lu; Wei Gong; Xuehong Dong; Xiaoyan Song; Weiwei Zhao; Jiefeng Cui; Yinkun Liu; Renming Hu
Journal:  Wien Klin Wochenschr       Date:  2015-05-19       Impact factor: 1.704

2.  Preliminary study of hypoxia-related cardiovascular mediator-markers in patients with end-stage renal disease with and without diabetes and the effects of haemodialysis.

Authors:  A Treweeke; J Hall; S Lambie; S J Leslie; I L Megson; S M MacRury
Journal:  PLoS One       Date:  2017-05-23       Impact factor: 3.240

3.  The triglyceride glucose index can predict newly diagnosed biopsy-proven diabetic nephropathy in type 2 diabetes: A nested case control study.

Authors:  Jin Shang; Dahai Yu; Yamei Cai; Zheng Wang; Bin Zhao; Zhanzheng Zhao; David Simmons
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

4.  Survival of patients from South Asian and Black populations starting renal replacement therapy in England and Wales.

Authors:  Paul Roderick; Catherine Byrne; Anna Casula; Retha Steenkamp; David Ansell; Richard Burden; Dorothea Nitsch; Terry Feest
Journal:  Nephrol Dial Transplant       Date:  2009-07-21       Impact factor: 5.992

5.  The impact of an "acute dialysis start" on the mortality attributed to the use of central venous catheters: a retrospective cohort study.

Authors:  Karthik K Tennankore; Steven D Soroka; Bryce A Kiberd
Journal:  BMC Nephrol       Date:  2012-07-30       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.